Latest Breaking News On - Cellular oncology department - Page 1 : comparemela.com

Electromedical Technologies and Nazarbayev University Complete Agreement to Expand Promising Joint Research Programs News provided by Share this article - Stage I research programs designed to study how electro-modulation communicates to cells - Program objective to d  and generating cellular response agreement EMED and Nazarbayev plan to begin the IDE process with the FDA SCOTTSDALE, Ariz., June 3, 2021 /PRNewswire/ Electromedical Technologies, Inc. (OTCQB: EMED) (the Company ), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+®, is pleased to announce that the Company recently completed an agreement with Nazarbayev University to expand its Stage I collaborative research programs. These Stage I programs will study how electro-modulation communicates to cells by modifying intracellular signaling events and altering physiological cellular response.

United statesGorod astanaRepublic of kazakhstanGalvani bioelectronicsKris fammMatthew wolfsonNazarbayev universityElectromedical technologies incWhitehead institute for biomedical researchPrnewswire electromedical technologies incNational laboratory astanaHanover internationalMd anderson cancer centerProfessor dos sarbassov at nazarbayev universityCellular oncology departmentResearch centers